Crinetics Pharmaceuticals, Inc. (CRNX) ownership: Top institutional holder: FMR LLC ($572.40M). Insider activity: Net Seller (0 buys, 20 sells). 5 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 15759799.00 | $572.40M | 2026-03-31 |
| VANGUARD GROUP INC | 9135504.00 | $425.26M | 2025-12-31 |
| BlackRock, Inc. | 8478815.00 | $307.95M | 2026-03-31 |
| FARALLON CAPITAL MANAGEMENT LLC | 8338098.00 | $302.84M | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 8157204.00 | $296.27M | 2026-03-31 |
| Driehaus Capital Management LLC | 6395922.00 | $232.30M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4673935.00 | $169.76M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4638511.00 | $168.47M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-04-08 | |
| Sell | null | 2026-04-08 | |
| Sell | null | 2026-04-08 |
Back to CRNX overview · CRNX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.